A study of pediatric patients with B-cell precursor acute lymphoblastic leukemia (BCP-ALL) identified mutations in the TSLP receptor CRLF2 with the highest frequency in 45 patients accounting for 14.3 % of all cases [62]. This evidence concerns the gene CRLF2 and acute lymphoblastic leukemia.